Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different-Reference-Cited by-同舟云学术

Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different

Published:2019-03-30 Issue:5 Volume:36 Page:1018-1030
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Cheng Alice Y. Y.^ORCID,Patel Dhiren K.,Reid Timothy S.,Wyne Kathleen

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-00925-6.pdf

Reference50 articles.

1. Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. The past, present, and future of basal insulins. Diabetes Metab Res Rev. 2016;32:478–96.

2. Heise T, Mathieu C. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes. Diabetes Obes Metab. 2017;19:3–12.

3. Pandyarajan V, Weiss MA. Design of non-standard insulin analogs for the treatment of diabetes mellitus. Curr Diab Rep. 2012;12:697–704.

4. Anderson JE. An evolutionary perspective on basal insulin in diabetes treatment: innovations in insulin: insulin glargine U-300. J Fam Pract. 2016;65:S23–8.

5. Korsatko S, Deller S, Koehler G, et al. A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec. Clin Drug Investig. 2013;33:515–21.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses;International Journal of Biological Macromolecules;2024-06

2. How to Improve the Quality of Euglycemic Glucose Clamp Tests in Long-Acting Insulin Studies;2024-05-23

3. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

4. Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients;Endocrines;2024-05-09

5. Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials;Endocrinology, Diabetes & Metabolism;2024-04-24